GNPX logo

Genprex (GNPX) Company Overview

Profile

Full Name:

Genprex, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 29, 2018

Indexes:

Not included

Description:

Genprex, Inc. (GNPX) is a biotechnology company focused on developing innovative gene therapies for cancer treatment. Their lead product, Oncoprex, aims to improve outcomes for patients with non-small cell lung cancer by targeting specific genetic mutations. The company is dedicated to advancing personalized medicine in oncology.

Events Calendar

Earnings

Next earnings date:

May 15, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 30, 2020
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 2, 2024

Analyst ratings

Recent major analysts updates

May 17, 24 HC Wainwright & Co.
Buy
May 15, 24 HC Wainwright & Co.
Buy
Apr 4, 24 HC Wainwright & Co.
Buy
Apr 3, 24 HC Wainwright & Co.
Buy
Mar 25, 24 HC Wainwright & Co.
Buy
Jan 30, 23 Dawson James
Buy
Sep 14, 18 Maxim Group
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Genprex?
  • Does Genprex pay dividends?
  • What sector is Genprex in?
  • What industry is Genprex in?
  • What country is Genprex based in?
  • When did Genprex go public?
  • Is Genprex in the S&P 500?
  • Is Genprex in the NASDAQ 100?
  • Is Genprex in the Dow Jones?
  • When was Genprex's last earnings report?
  • When does Genprex report earnings?
  • Should I buy Genprex stock now?

What is the ticker symbol for Genprex?

The ticker symbol for Genprex is NASDAQ:GNPX

Does Genprex pay dividends?

No, Genprex does not pay dividends

What sector is Genprex in?

Genprex is in the Healthcare sector

What industry is Genprex in?

Genprex is in the Biotechnology industry

What country is Genprex based in?

Genprex is headquartered in United States

When did Genprex go public?

Genprex's initial public offering (IPO) was on March 29, 2018

Is Genprex in the S&P 500?

No, Genprex is not included in the S&P 500 index

Is Genprex in the NASDAQ 100?

No, Genprex is not included in the NASDAQ 100 index

Is Genprex in the Dow Jones?

No, Genprex is not included in the Dow Jones index

When was Genprex's last earnings report?

Genprex's most recent earnings report was on Nov 13, 2024

When does Genprex report earnings?

The next expected earnings date for Genprex is May 15, 2025

Should I buy Genprex stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions